(Q43919320)

28 November 2017

Increased circulating levels of soluble Fas ligand are correlated with disease activity in patients with fibrosing lung diseases (English)

1 reference

28 November 2017

1

Kazuyoshi Kuwano

1 reference

28 November 2017

Takashige Maeyama

2

1 reference

28 November 2017

Ichiro Inoshima

3

1 reference

28 November 2017

Kiyoshi Ninomiya

4

1 reference

28 November 2017

Naoki Hagimoto

5

1 reference

28 November 2017

Michihiro Yoshimi

6

1 reference

28 November 2017

Masaki Fujita

7

1 reference

28 November 2017

Norio Nakamura

8

1 reference

28 November 2017

Kamon Shirakawa

9

1 reference

28 November 2017

Nobuyuki Hara

10

1 reference

28 November 2017

1 March 2002

1 reference

28 November 2017

1 reference

28 November 2017

7

1 reference

28 November 2017

15-21

1 reference

28 November 2017

1

1 reference

The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis

28 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2002.00369.X

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2002.00369.X

Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2002.00369.X

Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2002.00369.X

Metalloproteinase-mediated release of human Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2002.00369.X

Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2002.00369.X

Standardization of Spirometry, 1994 Update. American Thoracic Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2002.00369.X

Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2002.00369.X

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2002.00369.X

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2002.00369.X

NF-kappaB determines localization and features of cell death in epidermis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2002.00369.X

Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2002.00369.X

Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1843.2002.00369.X

10.1046/J.1440-1843.2002.00369.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference